Design, synthesis and the evaluation of cholinesterase inhibition and blood‐brain permeability of daidzein derivatives or analogs
Chemical Biology & Drug Design · 2023
DOI: 10.1111/cbdd.14279 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2023. Verfasst von Yi-Hui Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Chemical Engineering, Hu'nan University, Changsha, China. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Tandem Mass Spectrometry. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
In the present study, a series of derivatives and analogs of daidzein were designed and synthesized to investigate cholinesterase inhibition and blood–brain barrier permeability. The enzyme assay showed that most of the compounds containing a tertiary amine group exhibit moderate cholinesterase inhibition, 7‐hydroxychromone derivatives (absence of B ring of daidzein scaffold) only have a weaker bioactivity, while those compounds without the tertiary amine group have no bioactivity. Among them compound 15a (4’‐ N,N ‐dimethylaminoethoxy‐7‐methoxyisoflavone) appeared the best inhibitory activity (IC 50 : 2.14 ± 0.31 μmol/L) and higher selectivity for AChE over BuChE (Ratio: 7.07). It was selected for the further investigation by UPLC‐MS/MS. The results show that C Brain/Serum of compound 15a in mice was more than 2.87 within 240 min. This discovery may provide worthy information for the future development of central nervous drugs including but not limited to cholinesterase inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemistry and Chemical Engineering, Hu'nan University, Changsha, China.
- College of Pharmacy, Changsha health Vocational College, Changsha, China.
- Department of Traditional Chinese Medicine, Affiliated Dongguan Hospital, Southern Medical University, Dongguan, China.
ORCID-Profile: Hao-Ran Liu
Zitieren
APA
Wang, Y. H., Gao, X. H., Li, X., Ding, Y. J., Shi, Q., Yang, Z. Y., Peng, D., & Liu, H. R. (2023). Design, synthesis and the evaluation of cholinesterase inhibition and blood‐brain permeability of daidzein derivatives or analogs. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14279
Vancouver
Wang YH, Gao XH, Li X, Ding YJ, Shi Q, Yang ZY, et al. Design, synthesis and the evaluation of cholinesterase inhibition and blood‐brain permeability of daidzein derivatives or analogs. Chemical Biology & Drug Design. 2023. doi:10.1111/cbdd.14279
BibTeX
@article{Wang2023,
author = {Wang, Yi-Hui and Gao, Xiao-Hui and Li, Xuan and Ding, Yu-Jie and Shi, Qing and Yang, Zhi-Yu and Peng, Dian and Liu, Hao-Ran},
title = {Design, synthesis and the evaluation of cholinesterase inhibition and blood‐brain permeability of daidzein derivatives or analogs},
journal = {Chemical Biology & Drug Design},
year = {2023},
doi = {10.1111/cbdd.14279}
}
EUVIMED